Rui Miguel Pinheiro Vitorino - Nanotechnology

Author Information

Rui Miguel Pinheiro Vitorino is a distinguished researcher affiliated with iBiMED, Department of Medical Sciences at the University of Aveiro in Aveiro, Portugal. His work primarily revolves around the fields of nanotechnology, proteomics, and biomarker discovery, with particular interest in medical applications such as cancer diagnostics, cardiovascular diseases, and neurodegenerative disorders.

Research Contributions

Rui Miguel Pinheiro Vitorino has made significant contributions to the field of nanotechnology and proteomics. His recent works in 2022 include studies on the immunomodulatory effects of exosome-loaded oligonucleotides in wound healing, the application of proteogenomics in identifying novel biomarkers for prostate cancer, and the development of a systematic framework for lipid nanoparticles. His research also delves into the proteomic analysis of pericardial fluid to identify markers of atrial fibrillation and explores the role of exosomal content in heart failure patients. His earlier works include the use of gold nanoparticles for biodetection in urine and the identification of exosome-derived mediators as potential biomarkers for cardiovascular diseases.

Aliases

Rui Miguel Pinheiro Vitorino is also known by several aliases including R. Vitorino, Rui P Vitorino, Rui Vitorino, Rui M P Vitorino, and R Vitorino.

Publication and Citation Metrics

Citation Count	6490
H-index	42
Paper Count	288

Publications:

3D-MSCs A151 ODN-Loaded Exosomes Are Immunomodulatory And Reveal A Proteomic Cargo That Sustains Wound Resolution

DOI: 10.1016/j.jare.2022.01.013

Year: 2022

Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study

DOI: 10.3390/cancers14082001

Year: 2022

Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma.

DOI: 10.1007/s00438-022-01866-6

Year: 2022

EXERCISE TRAINING IMPROVES THE EXOSOMAL CONTENT IN PATIENTS WITH HEART FAILURE

DOI: 10.1016/s0735-1097(22)02582-7

Year: 2022

A Stepwise Framework for the Systematic Development of Lipid Nanoparticles

DOI: 10.3390/biom12020223

Year: 2022

Pericardial Fluid Annexin A1 Is a Marker of Atrial Fibrillation in Aortic Stenosis: A Proteomics Analysis

DOI: 10.3390/jpm12020264

Year: 2022

Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers.

DOI: 10.1021/acs.jproteome.1c00763

Year: 2022

Gold nanoparticles-based assays for biodetection in urine.

DOI: 10.1016/j.talanta.2021.122345

Year: 2021

Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach

DOI: 10.3390/proteomes9010008

Year: 2021

Bioinformatic analysis of the human brain extracellular matrix proteome in neurodegenerative disorders

DOI: 10.1111/ejn.15316

Year: 2021

What are the Challenges in Achieving Robust Design?

Why is Probe Design Important?

How are Monodisperse Particles Synthesized?

What is Protein in the Context of Nanotechnology?

What are Some Common Enhanced Imaging Techniques?

What are Nanodiamond Coatings?

What is the NBMC?

What is GROMACS?

How Does FinFET Work?

How are Collaborations Facilitated in These Laboratories?

Partnered Content Networks

Relevant Topics